Close

Zymeworks (ZYME) Announces Expanded Bispecific Antibody Collaboration with Celgene Corp. (CELG)

April 23, 2018 4:16 PM EDT Send to a Friend
Zymeworks Inc. (NYSE: ZYME) today announced that Celgene Corporation (NASDAQ: CELG) has exercised its right to expand its collaboration agreement ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login